Chronic immune-related adverse events often persist years after adjuvant anti–PD-1 immunotherapy for high-risk melanoma and may require prolonged monitoring and management, researchers say.
Primary care might be the first setting where AI-driven tools allow for broader access to effective melanoma screening, amid continuing challenges in developing consumer apps for this purpose.
A new analysis found that relapse-free survival is a poor surrogate endpoint for overall survival in adjuvant immunotherapy trials in a variety of cancer types.
It is crucial that we find ways to educate adolescents on the importance of sunscreen use and target those populations who were found to rarely use sunscreen in our study, one of the authors said.